Is Innova Captab the Best Stock in Its Sector? A Look at the Numbers
- September 29, 2026
- Posted by: Kunal Singla
- Category: Market
Innova Captab CMP Rs 1,292 (29 Sep 2026). Market cap Rs 7,275 Cr. ROE 12.92%. P/E 47.23x versus Industry P/E 38.42x.
Quick Answer
Innova Captab is one of the names investors compare when screening the Healthcare sector, built on a 12.92% return on equity and a P/E of 47.23x against an Industry P/E of 38.42x. Whether Innova Captab is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.
Is Innova Captab the best stock in its sector? The stock trades on the NSE at Rs 1,292 as of 29 September 2026, within its 52-week range of Rs 622.00 to Rs 1,353.50. Innova Captab Ltd makes pharmaceutical formulations, including as a contract development and manufacturing partner for other companies.
Innova Captab sits in the Healthcare sector, and its 12.92% ROE and 47.23x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.
Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers
Click Here – Get Free Investment Predictions
About Innova Captab
Innova Captab Ltd makes pharmaceutical formulations, including as a contract development and manufacturing partner for other companies. The stock has roughly doubled from its 52-week low and is trading close to its 52-week high. At a market capitalisation of Rs 7,275 Cr, it is tracked as part of the Healthcare sector on Univest.
Is Innova Captab the Best Stock in Its Sector?
Innova Captab makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, combining a 12.92% ROE with a 47.23x P/E against the sector’s 38.42x Industry P/E. Innova Captab’s 47.23x P/E is above the 38.42x Industry P/E and a 6.67x price to book is demanding for a 12.92% ROE, after a rally of roughly 100 percent from its 52-week low.
| Metric | Innova Captab |
|---|---|
| CMP (NSE) | Rs 1,291.90 |
| 52-Week High / Low | Rs 1,353.50 / Rs 622.00 |
| Market Cap | Rs 7,275 Cr |
| P/E (TTM) vs Industry P/E | 47.23x vs 38.42x |
| P/B | 6.67 |
| ROE | 12.92% |
| EPS (TTM) | Rs 26.92 |
| Dividend Yield | 0.16% |
| Debt to Equity | 0.32 |
Compare Innova Captab Against Other Healthcare Sector Stocks
How Innova Captab Compares Against Its Healthcare Sector Peers
The table below sets Innova Captab against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.
| Company | Market Cap (Rs Cr) | P/E | ROE | Debt to Equity |
|---|---|---|---|---|
| Innova Captab | 7,275 | 47.23 | 12.92% | 0.32 |
| Gufic Biosciences | 4,224 | 57.55 | 9.66% | 0.61 |
| CORONA Remedies | 13,237 | 66.51 | 24.79% | 0.22 |
| Peer average (2 companies) | – | 62.03 | 17.23% | 0.41 |
Against this peer set, Innova Captab’s 12.92% ROE is below the 17.23% peer average, and its P/E of 47.23x runs below the peer average of 62.03x. Innova Captab’s 47.23x P/E is above the 38.42x Industry P/E and a 6.67x price to book is demanding for a 12.92% ROE, after a rally of roughly 100 percent from its 52-week low.
What Makes Innova Captab Worth Watching in Healthcare
- Solid ROE: A 12.92% ROE is a reasonable figure for a contract pharma manufacturer.
- Moderate leverage: A debt to equity ratio of 0.32 is manageable.
- Sharp rally toward its high: The share price has roughly doubled from its 52-week low, so much of the improvement is already priced in.
Innova Captab Valuation: Is It Justified?
Innova Captab’s 47.23x P/E is above the 38.42x Industry P/E and a 6.67x price to book is demanding for a 12.92% ROE, after a rally of roughly 100 percent from its 52-week low. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.
Also read – Is Indegene the Best Stock in Its Sector? A Look at the Numbers
Download the Univest iOS App or Univest Android App to track Innova Captab and other Healthcare sector stocks.
How to Track Innova Captab Before You Invest
Before deciding whether Innova Captab deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.
- Open the Univest Screener and search for Innova Captab to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
- Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
- Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
- Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.
Conclusion
Innova Captab earns a place in the best stock in its sector conversation on the strength of a 12.92% ROE and a P/E of 47.23x against a 38.42x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Is Innova Captab the best stock in its sector?
Ans. Innova Captab has a 12.92% ROE and trades at 47.23x P/E against a 38.42x Industry P/E, and compares below the peer average ROE of 17.23% in this article’s named comparison, so the answer depends on what an investor is prioritising.
What is the current share price of Innova Captab?
Ans. Innova Captab was trading at Rs 1,291.90 on the NSE as of 29 September 2026, within its 52-week range of Rs 622.00 to Rs 1,353.50.
What sector does Innova Captab belong to?
Ans. Innova Captab is classified under the Healthcare sector on Univest.
How does Innova Captab compare to its sector peers on P/E?
Ans. Innova Captab’s P/E of 47.23x is below the 62.03x average of the 2 named peers compared in this article.
What is Innova Captab’s return on equity?
Ans. Innova Captab reported a return on equity of 12.92%, which is below the 17.23% average of its named peers in this comparison.
Should I invest in Innova Captab based on its sector position?
Ans. Innova Captab’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.
